BeiGene | Study Investigating BGB-24714 as Monotherapy and in Combination With Chemotherapy in Participants With Advanced or Metastatic Solid Tumors

⟵ Back to Search Results

A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors

Beigene Study ID

BGB-24714-101

ClinicalTrials.gov ID

NCT05381909

China Drug Trials ID

CTR20232532

Sex: All

Age: 18 Years / N/A

No Study Documents

Locations

Sex: All

Age: 18 Years / N/A

No Study Documents